Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SYNB 1020

Drug Profile

SYNB 1020

Alternative Names: SYNB-1020

Latest Information Update: 27 Aug 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Synlogic
  • Class Probiotics
  • Mechanism of Action Ammonia scavengers; Microbiome modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Inborn urea cycle disorders
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Hyperammonaemia; Inborn urea cycle disorders; Liver cirrhosis

Most Recent Events

  • 20 Aug 2019 Discontinued - Phase-I/II for Hyperammonaemia (In the elderly, In adults), Liver cirrhosis (In the elderly, In adults) and Inborn urea cycle disorders in USA as SYNB 1020 did not indicate an activity profile in ammonia-lowering (PO)
  • 20 Aug 2019 Interim adverse events and pharmacodynamic data from a phase Ia/IIb trial in Cirrhosis and Hyperammonaemia released by Synlogic
  • 16 Jan 2019 Efficacy and safety results from the phase I trial were released by Synlogic
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top